Neurotrack is dedicated to the development of non-invasive cognitive health assessment tools that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline, and help advance research of treatments for cognitive diseases, including Alzheimer's.
What We Do:
Neurotrack has developed Imprint™, a 5-minute computer-based test that, through tracking of eye movements, detects cognitive impairment. The test has been validated by a five-year longitudinal NIH-sponsored study and is currently being used by leading research institutions and pharmaceutical companies in clinical studies.
Based on research findings demonstrating that the management of lifestyle risk factors can reduce the risk of cognitive decline, Neurotrack is also developing a complementary cognitive health program to support better nutrition, regular exercise, stress reduction, adequate sleep and cognitive training designed to preserve mental acuity.